Kawasaki Disease
55
10
11
23
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 55 trials
100.0%
+13.5% vs benchmark
24%
13 trials in Phase 3/4
30%
7 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (55)
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Cardiovascular Status of Children 5 Years After Kawasaki Disease
MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Kawasaki MATCH Trial
European and North Indian Cohort of KaWasaki dIsease
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Cardiovascular Risk in Children With Chronic Conditions Study
Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
Non Inferiority KawasakI Trial With Anakinra
Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
The Value of Cardiovascular Imaging in Kawasaki Disease